Still, the overall limited association of outcome of patients with grade 2 versus 3 3 IDH-mutant glioma patients reflects the biological continuum of these tumor grades implying that a sharp distinction between these grades is artificial. This evidence concerns the gene IDH2 and central nervous system cancer.